Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
Children's Hospital Medical Center, Cincinnati · NCT02986087
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- November 2016
- Record last updated
- May 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.
Being studied: Fetal Tracheal Occlusion
Conditions: Congenital Diaphragmatic Hernia; Pulmonary Hypoplasia; Pulmonary; Hypertension
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Isolated CDH with liver up
- Severe pulmonary hypoplasia with ultrasound O/E LHR \<25% at the time of surgery
- Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days
- Moderate pulmonary hypoplasia with ultrasound O/E LHR \<30% and liver-up at the time of surgery
- Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category
- Maternal age greater than or equal to 18 years
- Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category
- Normal karyotype or FISH
- Normal fetal echocardiogram
- Singleton pregnancy
- Willing to remain in the greater Cincinnati area for remainder of pregnancy
- Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days
- Family meets psychosocial criteria
Exclusion Criteria
- Patient \< 18 years old
- Multi-fetal pregnancy
- Rubber latex allergy
- Preterm labor, cervix shortened (\<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa
- Bilateral CDH, isolated left sided CDH with an O/E > 30%
- Additional fetal anomaly by ultrasound, MRI, or echocardiogram
- Chromosomal abnormalities
- Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy
- Incompetent cervix with or without a cerclage
- Placental abnormalities known at time of enrollment
- Maternal HIV, Hepatits B, Hepatitis C
- Maternal uterine anomaly
- No safe or technically feasible fetoscopic approach to balloon placement
- Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy
Recruiting US locations
Cincinnati Children's Hospital Medical Center (CCHMC)
Cincinnati, OH 45229
Site contact: Foong-Yen Lim, MD · 513-803-5270 · Foong.Yen.Lim@cchmc.org
Study contacts (from the official record)
- Foong-Yen Lim, MD · (513) 636-6259 · Foong-Yen.Lim@cchmc.org
- Jose Peiro, MD, PhD · (513) 803-4563 · Jose.Peiro@cchmc.org
Similar studies in Ohio
All heart & blood pressure studies in Ohio →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Cincinnati, OH + 30 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Cleveland, OH + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Lima, OH + 27 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Boston Scientific Corporation
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 18+